Hepatitis C treatment at a fraction of the cost to be available soon


PETALING JAYA: Affordable Hepatitis C treatment will soon be available for patients once trials on generic drugs are completed.

The non-profit Drugs for Neglected Diseases initiative (DNDi), of which the Malaysian Health Ministry is a founding member, and Egyptian drug manufacturer Pharco Pharmaceuticals on Wednesday signed agreements covering clinical testing and scale-up of a Hepatitis C treatment regimen at a price of just under US$300 (RM1,166) at the International Liver Congress 2016 in Barcelona, Spain.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Sarawak containing African Swine Fever to Tebedu, other districts uninfected, says Dr Stephen Rundi
Floods: Kelantan govt suffers over RM30mil losses in first wave
Highlights of Parliament's third session include tabling of Budget 2025, says Dr Wee on its last day
Factory supervisor, manager arrested for river pollution in Pasir Gudang
Sabah Energy Council approves 15 bids for 199MW large-scale solar projects
Ramanan honours polls pledge, channels MP salary to community welfare
Malaysian Media Council Bill tabled for first reading in Parliament
PAC gunning for Khanazah Nasional and health insurance among its five key cases next year
Bersatu is rooted in Sabah, focuses on championing MA63 rights, says state Armada chief
Bullying could be a problem in NS 3.0, says Parliament Special Select Committee

Others Also Read